montelukast
UkraineDrugs containing this active substance
-
The drug is used to reduce the symptoms of seasonal and perennial allergic rhinitis, as well as rhinitis in people suffering from bronchial asthma.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg levocetirizine 5 mg Manufacturer: Bafna Pharmaceuticals Ltd.
-
The drug is used for the add-on treatment of mild to moderate bronchial asthma, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. It is also used for the prevention of exercise-induced asthma.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: LLC "Agrofarm" (packaging from bulk by manufacturer GenePharm S.A., Greece and batch release)
-
The drug is used for the prevention and treatment of bronchial asthma (including exercise-induced asthma), as well as for the relief of symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: LLC "Agrofarm" (packaging from bulk by manufacturer GenePharm S.A., Greece and batch release)
-
The drug is used for the prevention and treatment of bronchial asthma (as add-on therapy or an alternative to inhaled corticosteroids), as well as to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: LLC "Agrofarm" (packaging from bulk by manufacturer GenePharm S.A., Greece and batch release)
-
The drug is used as add-on treatment for bronchial asthma in children aged 2 to 5 years, as well as for the prevention of exercise-induced asthma. It also helps relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Torrent Pharmaceuticals Ltd
-
The drug is used as add-on treatment for bronchial asthma (mild to moderate) that is not adequately controlled by other agents. It also helps in the prevention of exercise-induced asthma and alleviates the symptoms of seasonal or perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Torrent Pharmaceuticals Ltd
-
The drug is used as add-on treatment for bronchial asthma (if other agents do not provide full control), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Torrent Pharmaceuticals Ltd.
-
The drug is used for the symptomatic treatment of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg levocetirizine 5 mg ATC: R03DC53
Manufacturer: Dr. Reddy's Laboratories Limited
-
The drug is used as add-on treatment for bronchial asthma (if standard inhalers do not provide full control), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
The drug is used as add-on treatment for bronchial asthma (mild to moderate forms), for the prevention of exercise-induced asthma, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
The drug is used as an add-on treatment for bronchial asthma (mild to moderate forms), for the prevention of exercise-induced asthma, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
The drug is intended to reduce the symptoms of seasonal and perennial allergic rhinitis, as well as rhinitis in people suffering from bronchial asthma.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg levocetirizine 5 mg ATC: R07AX
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
It is used as add-on treatment for bronchial asthma (if other agents do not provide full control), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is used as add-on treatment for bronchial asthma in children from 6 months to 5 years of age, as well as for the prevention of exercise-induced asthma in children from 2 years of age.
Form: granules
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and for the symptomatic treatment of seasonal allergic rhinitis in patients with asthma.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Pharma International Company
-
The drug is used as add-on treatment for bronchial asthma in children aged 2 to 5 years, as well as for the prevention of exercise-induced asthma in patients from 2 years of age. It also helps relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Aurobindo Pharma Limited - Unit VII
-
The drug is used as add-on treatment for bronchial asthma (mild to moderate) that is not adequately controlled by other agents. It also helps prevent exercise-induced asthma and relieves symptoms of seasonal or perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Aurobindo Pharma Limited - Unit VII
-
The drug is used for the prevention and treatment of bronchial asthma (including exercise-induced asthma), as well as to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: JSC "Adamed Pharma" (manufacturer "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used for the prevention and treatment of bronchial asthma (as add-on therapy or an alternative to inhaled corticosteroids), as well as to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: JSC "Adamed Pharma" (manufacturer “in bulk”, primary and secondary packaging, quality control and batch release)
-
The drug is used as add-on treatment for bronchial asthma (when control with other agents is insufficient), for the prevention of exercise-induced asthma, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: JSC "Adamed Pharma" (manufacturer "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Hetero Labs Limited
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Hetero Labs Limited
-
The drug is used for the add-on treatment of mild to moderate bronchial asthma, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. It is also used for the prevention of exercise-induced asthma.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
-
The drug is used for the prevention and treatment of bronchial asthma (including exercise-induced asthma), as well as for the relief of symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
-
The drug is used for the prevention and treatment of bronchial asthma (including exercise-induced asthma), as well as for the relief of symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Intas Pharmaceuticals Limited (manufacturing of medicinal product, primary and secondary packaging, quality control of batch)
-
The drug is used for the add-on treatment of bronchial asthma in children from 6 months to 5 years of age, as well as for the prevention of exercise-induced asthma in patients from 2 years of age.
Form: granules
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Laboratorios Normon, S.A.
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Laboratorios Normon, S.A.
-
The drug is used as add-on treatment for bronchial asthma (mild to moderate), for the prevention of exercise-induced asthma, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Teva Operations Poland LLC
-
The drug is used for the add-on treatment of bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Teva Operations Poland LLC
-
The drug is used for the add-on treatment of bronchial asthma (if it is not sufficiently controlled by other means), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Teva Operations Poland LLC
-
The drug is used as add-on treatment for bronchial asthma (if other agents do not provide full control), for the prevention of exercise-induced asthma, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used for the prevention of bronchial asthma (including exercise-induced asthma), as add-on therapy for asthma that is poorly controlled by other agents, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used for the prevention of bronchial asthma (including exercise-induced asthma), as add-on therapy for asthma that is poorly controlled by other agents, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used for the symptomatic treatment of seasonal and perennial allergic rhinitis.
Form: tablets
Active substance Dosage montelukast 10 mg levocetirizine 5 mg ATC: R03DC53
Manufacturer: Mankind Pharma Limited, Unit-II
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Kusum HealthCare Pvt Ltd
-
The drug is used as add-on treatment for bronchial asthma in children aged 2 to 5 years, as well as for the prevention of exercise-induced asthma. It also helps relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Kusum HealthCare Pvt Ltd
-
The drug is prescribed to children aged 6 to 14 years as add-on treatment for bronchial asthma, for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Kusum HealthCare Pvt Ltd
-
The drug is used for the treatment of bronchial asthma (as an add-on therapy or an alternative to inhaled corticosteroids) and for its prevention. It also helps relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
The drug is used for the treatment of bronchial asthma (as add-on therapy when control with other agents is insufficient or for the prevention of exercise-induced asthma), as well as for the relief of symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: PJSC "Gedeon Richter" (batch release)
-
The drug is used for the treatment of bronchial asthma (as an add-on therapy or an alternative to inhaled corticosteroids) and for its prevention. It also helps relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
The drug is used as add-on treatment for bronchial asthma (in children aged 2 to 5 years), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
Manufacturer: Organon Pharma (UK) Limited (manufacturer of unpackaged product, primary and secondary packaging, quality control)
-
The drug is used as add-on treatment for bronchial asthma (mild to moderate) that is not adequately controlled by other medications. It is also used for the prevention of exercise-induced asthma and to relieve the symptoms of seasonal or perennial allergic rhinitis.
Form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
Manufacturer: Organon Pharma (UK) Limited (manufacturer of unpackaged product, primary and secondary packaging, quality control)
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
Manufacturer: Merck Sharp & Dohme B.V. (primary and secondary packaging, quality control, batch release authorization)